Ulf Andréasson
Impact in
- Psychiatry and Mental health top 0.1%
- Dementia and Cognitive Impairment Research
- Physiology top 0.1%
- Alzheimer's disease research and treatments
Papers in
- Physiology 71
- Alzheimer's disease research and treatments 71
-
- Dementia and Cognitive Impairment Research 44
- Co-authors
- Henrik Zetterberg (157 shared papers)Kaj Blennow (148 shared papers)Niklas Mattsson (32 shared papers)Erik Portelius (48 shared papers)Oskar Hansson (29 shared papers)Lennart Minthon (19 shared papers)Niklas Norgren (8 shared papers)Maria Bjerke (12 shared papers)
- Journals
- Journal of Alzheimer s Disease (18 papers)Alzheimer s & Dementia (16 papers)Alzheimer s Research & Therapy (11 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (7 papers)Neurology (5 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Ulf Andréasson
171 papers receiving 13.8k citations
Ulf Andréasson's Hit Papers
Peers
Comparison fields: 5 of 160
- Psychiatry and Mental health 3.8k
- Physiology 5.8k
- Neurology 1.8k
- Neurology 2.6k
- Biological Psychiatry 256
Countries citing papers authored by Ulf Andréasson
This map shows the geographic impact of Ulf Andréasson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Andréasson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Andréasson more than expected).
Fields of papers citing papers by Ulf Andréasson
This network shows the impact of papers produced by Ulf Andréasson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Andréasson. The network helps show where Ulf Andréasson may publish in the future.
Co-authors
The 25 scholars most cited alongside Ulf Andréasson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 178 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis Hit paper breakdown → | 2016 | 1448 |
| 2 | Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease Hit paper breakdown → | 2017 | 713 |
| 3 | Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa Hit paper breakdown → | 2016 | 555 |
| 4 | Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease Hit paper breakdown → | 2019 | 485 |
| 5 | Plasma tau in Alzheimer disease Hit paper breakdown → | 2016 | 386 |
| 6 | Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders Hit paper breakdown → | 2012 | 368 |
| 7 | Blood-based NfL Hit paper breakdown → | 2017 | 367 |
| 8 | Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study Hit paper breakdown → | 2015 | 358 |
| 9 | Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia Hit paper breakdown → | 2016 | 325 |
| 10 | 2013 | 304 | |
| 11 | 2014 | 286 | |
| 12 | 2016 | 282 | |
| 13 | 2014 | 258 | |
| 14 | 2015 | 247 | |
| 15 | 2007 | 242 | |
| 16 | 2018 | 232 | |
| 17 | 2008 | 230 | |
| 18 | Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative Hit paper breakdown → | 2020 | 226 |
| 19 | 2015 | 203 | |
| 20 | 2008 | 184 |
About Ulf Andréasson
Ulf Andréasson is a scholar working on Physiology, Psychiatry and Mental health, Molecular Biology, Neurology and Neurology, having authored 178 papers that have together received 13.9k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (71 papers), Dementia and Cognitive Impairment Research (44 papers), Neuroinflammation and Neurodegeneration Mechanisms (10 papers), Computational Drug Discovery Methods (9 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers), S100 Proteins and Annexins (8 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). The work is most often cited by research in Psychiatry and Mental health (3.8k citations), Physiology (5.8k citations), Neurology (1.8k citations), Neurology (2.6k citations) and Biological Psychiatry (256 citations). Ulf Andréasson has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Henrik Zetterberg, Kaj Blennow, Niklas Mattsson, Erik Portelius, Oskar Hansson, Lennart Minthon, Niklas Norgren, Maria Bjerke, Annika Öhrfelt and Bob Olsson. Their work appears in journals such as Journal of Alzheimer s Disease, Alzheimer s & Dementia, Alzheimer s Research & Therapy, Clinical Chemistry and Laboratory Medicine (CCLM) and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.